Skip to main content

Published locations for 52-week data show lebrikizumab atopic dermatitis effects maintained

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. 52-week data show lebrikizumab atopic dermatitis effects maintained

User login

  • Reset your password
  • /content/52-week-data-show-lebrikizumab-atopic-dermatitis-effects-maintained
  • /clinicianreviews/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic-dermatitis
  • /edermatologynews/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic-dermatitis
  • /familypracticenews/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic-dermatitis
  • /fedprac/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic-dermatitis-effects
  • /internalmedicinenews/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic
  • /internalmedicine/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic-dermatitis
  • /dermatology/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic-dermatitis
  • /familymedicine/article/258418/atopic-dermatitis/52-week-data-show-lebrikizumab-atopic-dermatitis